Jon Rappoport
The first court test of Bayer/J&J’s billion-dollar bonanza, blood-thinner, Xarelto, is coming up in New Orleans next week. The outcome will influence how the 18,000 lawsuits behind it will be handled.
The plaintiff in the first suit is Joseph Boudreaux. “While Xarelto was supposed to help cut his stroke risk, Boudreaux says it instead caused internal bleeding that required a week-long hospital stay in the intensive-care unit, several blood transfusions and multiple heart procedures. ‘I don’t want anybody else to suffer like I have from that drug,’ the part-time security guard says,” reports the Chicago Tribune. Continue reading “Blood-thinning drug Xarelto faces 18,000 lawsuits”